Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2012 2
2013 1
2014 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance.
Krisnawan VE, Stanley JA, Schwarz JK, DeNardo DG. Krisnawan VE, et al. Among authors: stanley ja. Cancers (Basel). 2020 Oct 11;12(10):2916. doi: 10.3390/cancers12102916. Cancers (Basel). 2020. PMID: 33050580 Free PMC article. Review.
Single-Institution Phase 1/2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial-Breast Irradiation for Hormone Sensitive Stage 0-I Breast Cancer.
Kennedy WR, Thomas MA, Stanley JA, Luo J, Ochoa LL, Clifton KK, Cyr AE, Margenthaler JA, DeWees TA, Price A, Kashani R, Green O, Zoberi I. Kennedy WR, et al. Among authors: stanley ja. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):344-352. doi: 10.1016/j.ijrobp.2020.02.021. Epub 2020 Feb 19. Int J Radiat Oncol Biol Phys. 2020. PMID: 32084524
Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage.
Jian W, Xu HG, Chen J, Xu ZX, Levitt JM, Stanley JA, Yang ES, Lerner SP, Sonpavde G. Jian W, et al. Among authors: stanley ja. Anticancer Drugs. 2014 Sep;25(8):878-86. doi: 10.1097/CAD.0000000000000114. Anticancer Drugs. 2014. PMID: 24714082
PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
Swindall AF, Stanley JA, Yang ES. Swindall AF, et al. Among authors: stanley ja. Cancers (Basel). 2013 Jul 26;5(3):943-58. doi: 10.3390/cancers5030943. Cancers (Basel). 2013. PMID: 24202328 Free PMC article.
Kinomic profiling approach identifies Trk as a novel radiation modulator.
Jarboe JS, Jaboin JJ, Anderson JC, Nowsheen S, Stanley JA, Naji F, Ruijtenbeek R, Tu T, Hallahan DE, Yang ES, Bonner JA, Willey CD. Jarboe JS, et al. Among authors: stanley ja. Radiother Oncol. 2012 Jun;103(3):380-7. doi: 10.1016/j.radonc.2012.03.014. Epub 2012 May 5. Radiother Oncol. 2012. PMID: 22561027 Free PMC article.
Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.
Nowsheen S, Cooper T, Stanley JA, Yang ES. Nowsheen S, et al. Among authors: stanley ja. PLoS One. 2012;7(10):e46614. doi: 10.1371/journal.pone.0046614. Epub 2012 Oct 11. PLoS One. 2012. PMID: 23071597 Free PMC article.
Dihydropyridine neuropeptide Y Y(1) receptor antagonists.
Poindexter GS, Bruce MA, LeBoulluec KL, Monkovic I, Martin SW, Parker EM, Iben LG, McGovern RT, Ortiz AA, Stanley JA, Mattson GK, Kozlowski M, Arcuri M, Antal-Zimanyi I. Poindexter GS, et al. Among authors: stanley ja. Bioorg Med Chem Lett. 2002 Feb 11;12(3):379-82. doi: 10.1016/s0960-894x(01)00761-2. Bioorg Med Chem Lett. 2002. PMID: 11814801
Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I, Bruce MA, Leboulluec KL, Iben LG, Mattson GK, McGovern RT, Hogan JB, Leahy CL, Flowers SC, Stanley JA, Ortiz AA, Poindexter GS. Antal-Zimanyi I, et al. Among authors: stanley ja. Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32. doi: 10.1016/j.ejphar.2008.06.032. Epub 2008 Jun 12. Eur J Pharmacol. 2008. PMID: 18573246